RoosterBio Inc. Launches Industry’s First Ready-to-Print Stem Cell Product

RoosterBio Inc today announces the commercial launch of the industry’s first Ready to Print (RTP) stem cell product designed specifically for bioprinters and tissue engineers, removing weeks of time from the cellular bioprinting process. The health care industry is trying to swiftly capitalize on manufacturing technologies that were additive, also known as 3D printing. Whether programmers are making prosthetic limbs or using living cells to bioprint human tissues and organs, experiments in this industry are progressing in a rate that is remarkable. RoosterBio’s 50 million cell RTP format is an unprecedented stem cell product layout providing you with substantial amounts of high quality human mesenchymal stem/stromal cells (hMSCs) in a uniquely constructed format to simplify and standardize the most complex and labor intensive aspects of bioprinting.